NCT03625791View on ClinicalTrials.gov

Validation of a Genetic Signature to Predict the Development of Sarcomas

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

June 19, 2022

Study Completion Date

June 19, 2022

Conditions
Genetic Signature in Development of Sarcomas
Interventions
BIOLOGICAL

blood sample

1 tube with 4 ml of blood per patient

Trial Locations (3)

21000

Centre Georges François Leclerc, Dijon

33076

Institu Bergonie, Bordeaux

94805

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT03625791 - Validation of a Genetic Signature to Predict the Development of Sarcomas | Biotech Hunter | Biotech Hunter